Imago BioSciences, Inc.

IMGODelisted Jan 11, 2023

Industry: Pharmaceutical Preparations
SEC CIK: 0001623715

SEC filings (opens in a new tab)

Imago BioSciences, Inc. was delisted on Jan 11, 2023; its insiders filed their last Form 4 on Jan 11, 2023; 106 institutions reported holding it in 13F filings for Q4 2022, worth $1.05B in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Imago BioSciences, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of IMGO: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	52	59	+7
Shares	25.7M	29.9M	+4.18M (+16.3%)
Value	$606.7M	$575.8M	−$30.9M (−5.1%)

New holders (13)

Institutions that held Imago BioSciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to IMGO in Q1 2022
Institution	Shares	Value	% of portfolio
Frazier Life Sciences Management, L.P.	2,971,274	$57.3M	4.88%
Matrix Capital Management Company, LP	308,044	$5.94M	0.07%
AlpInvest Partners B.V.	90,469	$1.74M	0.56%
Manufacturers Life Insurance Company, The	43,483	$915.2K	0.00%
Laurion Capital Management LP	40,000	$771.0K	0.02%
Rhumbline Advisers	17,881	$345.0K	0.00%
State of Wisconsin Investment Board	13,100	$252.0K	0.00%
MetLife Investment Management	12,570	$242.2K	0.00%
Bessemer Group Inc	12,339	$238.0K	0.00%
Barclays PLC	4,333	$83.0K	0.00%
Amalgamated Bank	2,145	$41.0K	0.00%
Amalgamated Financial Corp.	2,145	$41.0K	0.00%
Metropolitan Life Insurance Co	1,473	$28.4K	0.00%

Sold out (6)

Institutions that held Imago BioSciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of IMGO in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Frazier Management LLC	2,971,274	$70.4M
Millennium Management LLC	151,786	$3.60M
HRT Financial LP	65,989	$1.56M
D. E. Shaw & Co., Inc.	32,058	$760.0K
Susquehanna International Group, LLP	14,137	$335.0K
Squarepoint Ops LLC	11,305	$268.0K